G1 Therapeutics, Inc. - COM (GTHX)

Historical Portfolio Holders from Q2 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
14.3 M
Holdings value Q1 2024
$61.6 M
Value change Q1 2024
+$8.69 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
84
Number of buys Q1 2024
49
Number of sells Q1 2024
-33
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
3621LQ109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 14.3 M $61.6 M +$8.69 M $4.32 84
2023 Q4 12.6 M $38.5 M +$5.21 M $3.05 85
2023 Q3 10.9 M $15.8 M -$9.29 M $1.44 71
2023 Q2 15.5 M $38.5 M -$9.5 M $2.49 78
2023 Q1 19.2 M $51.5 M -$16.5 M $2.68 96
2022 Q4 22.9 M $124 M -$17.2 M $5.43 114
2022 Q3 23 M $287 M +$41.9 M $12.49 101
2022 Q2 19.6 M $97 M -$26.5 M $4.94 87
2022 Q1 24.1 M $183 M -$18.2 M $7.60 105
2021 Q4 26.3 M $269 M -$4.18 M $10.21 101
2021 Q3 22.6 M $304 M +$24.2 M $13.42 106
2021 Q2 24.6 M $539 M +$8.87 M $21.94 109
2021 Q1 24.2 M $581 M +$15.1 M $24.06 119
2020 Q4 25.5 M $459 M -$92.1 M $17.99 121
2020 Q3 29.3 M $339 M -$4.54 M $11.55 113
2020 Q2 26.9 M $654 M -$6.35 M $24.26 95
2020 Q1 26.2 M $289 M -$31.2 M $11.02 93
2019 Q4 30.2 M $798 M -$10.8 M $26.43 96
2019 Q3 28.9 M $658 M +$10.2 M $22.78 93
2019 Q2 28.1 M $863 M +$49.8 M $30.66 93
2019 Q1 27.4 M $456 M -$3.02 M $16.60 89
2018 Q4 27.4 M $525 M -$102 M $19.15 90
2018 Q3 26.5 M $1.38 B +$177 M $52.29 115
2018 Q2 23.1 M $1 B +$143 M $43.46 94
2018 Q1 20 M $741 M +$238 M $37.05 94
2017 Q4 13.6 M $270 M +$24 M $19.84 57
2017 Q3 12.3 M $289 M +$59.7 M $24.89 42
2017 Q2 9.97 M $174 M +$174 M $17.44 27